tiprankstipranks
RUA Life Sciences (GB:RUA)
LSE:RUA

RUA Life Sciences (RUA) Share Price & Analysis

1 Followers

RUA Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range8.50p - 58.75p
Previous Close10.5p
Volume142.26K
Average Volume (3M)627.83K
Market Cap
£6.52M
Enterprise Value5.51M
Total Cash (Recent Filing)£1.48M
Total Debt (Recent Filing)£475.00K
Price to Earnings (P/E)-1.3
Beta-0.18
Jul 17, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding62,060,272
10 Day Avg. Volume61,558
30 Day Avg. Volume627,827
Standard Deviation0.24
R-Squared0.07
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)9150.28
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

7.22%0.00%0.00%92.78%
0.00% Other Institutional Investors
92.78% Public Companies and
Individual Investors

RUA FAQ

What was RUA Life Sciences’s price range in the past 12 months?
RUA Life Sciences lowest share price was 8.50p and its highest was 58.75p in the past 12 months.
    What is RUA Life Sciences’s market cap?
    Currently, no data Available
    When is RUA Life Sciences’s upcoming earnings report date?
    RUA Life Sciences’s upcoming earnings report date is Jul 17, 2024 which is in 60 days.
      How were RUA Life Sciences’s earnings last quarter?
      RUA Life Sciences released its earnings results on Dec 18, 2023. The company reported -0.046p earnings per share for the quarter, missing the consensus estimate of N/A by -0.046p.
        Is RUA Life Sciences overvalued?
        According to Wall Street analysts RUA Life Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does RUA Life Sciences pay dividends?
          RUA Life Sciences does not currently pay dividends.
          What is RUA Life Sciences’s EPS estimate?
          RUA Life Sciences’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does RUA Life Sciences have?
          RUA Life Sciences has 62,060,272 shares outstanding.
            What happened to RUA Life Sciences’s price movement after its last earnings report?
            RUA Life Sciences reported an EPS of -0.046p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of RUA Life Sciences?
              Currently, no hedge funds are holding shares in GB:RUA
              ---

              RUA Life Sciences Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -73.07%
              12-Months-Change

              Fundamentals

              Return on Equity
              -40.56%
              Trailing 12-Months
              Asset Growth
              -27.94%
              Trailing 12-Months

              Company Description

              RUA Life Sciences

              RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's only operating segment; exploiting the value of its IP and know-how. Geographically, it derives most of the revenue from the USA and has a presence in Europe and the Rest of the world. It has developed biostable, implantable polymers, including technology such as Elast-Eon, Elast-Eon Carbonate Silicone, and Elast-Eon Reaction Injection Molding (RIM) technology. Also, the company has developed a range of large bore vascular grafts. The company earns its revenues in the form of royalties and license fees.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Faron Pharmaceuticals Oy
              OptiBiotix Health
              Genedrive
              Omega Diagnostics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis